The evolution of metformin therapy through the decades.

Diabetic foot ulcers put patients at increased risk of falling.

CKD risk not necessarily tied to albuminuria in patients with type 1 diabetes.

Lowering HbA1c worth the risk of urinary tract and genital infections?

Your patient has been newly diagnosed with type 2 diabetes (A1C 7.7%) and you have prescribed metformin. Metformin should be titrated to minimize which side effect? A. Rebound hyperglycemia B. Reactive hypoglycemia C. Weight gain D. Gastrointestinal-side effects Follow the link to see the answer.

How often do you recommend to your type 2 patients who are not on insulin to monitor their blood sugars daily? 1. Once a day 2. Twice a day 3. More than twice a day 4. Once a week or Less than daily Follow the link to share your response.

Are you tired of having to write down your Blood Sugar test results? Would you like a way to get ride of the pen and pencil? Well try Diabetes Tracker. We take the K.I.S.S. approach.

Scott Abbott is the Director of Medical Development at Valeritas. He shares information from his presentation at the ADA on how the V-Go insulin delivery device can be used in the real world.

Dr. Scott Abbott discusses the V-Go wearable insulin delivery device, which is like a wearable insulin pen; it uses rapid-acting insulin and is approved as a pump-like device.

In this Exclusive Interview, Scott Abbott talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California, about the use, benefits, and future of the V-Go insulin delivery system.